SR One Capital Management, LP
Position in ODTX — Odyssey Therapeutics, Inc.
CIK 1910264
Redwood City, CA
Position in ODTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$71,002,260
New position
Shares Held
3,794,883
first reported quarter
Ownership
7.90%
of shares outstanding
% of Portfolio
6.83%
of 13F equity value
Holder Rank
#2
of 58 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SR One Capital Management, LP holds $1,012,394,333 across 14 Biotechnology names. ODTX ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
2,401,868 | $295,285,651 | |
| 2 | ZBIO |
Zenas BioPharma, Inc.
|
5,037,854 | $127,860,734 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
2,038,763 | $111,194,134 | |
| 4 | AVLN |
Avalyn Pharma Inc.
|
3,308,649 | $108,920,725 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
6,526,476 | $94,438,107 | |
| 6 | ODTX |
Odyssey Therapeutics, Inc.
This page
|
3,794,883 | $71,002,260 | |
| 7 | ALMS |
Alumis Inc.
|
1,959,896 | $55,151,473 | |
| 8 | ORIC |
Oric Pharmaceuticals, Inc.
|
4,615,384 | $49,984,608 |
All Filings in ODTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,002,260 | 3,794,883 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||